oxazolidin-2-one has been researched along with Substance-Related Disorders in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chevalier, G; Gautier, S; Houfflin-Debarge, V; Joriot, S; Rakza, T | 1 |
| Autret-Leca, E; Beau-Salinas, F; Bensouda-Grimaldi, L; Cissoko, H; Jonville-Béra, AP | 1 |
| Buzath, A; Lampl, C; Sandor, PS; Yazdi, K | 1 |
3 other study(ies) available for oxazolidin-2-one and Substance-Related Disorders
| Article | Year |
|---|---|
Hydrops and fetal hypoplastic left heart: An unexpected improvement after cessation of maternal polysubstance abuse.
Topics: Adult; Alcoholism; Aortic Coarctation; Cannabis; Cocaine-Related Disorders; Epilepsy; Female; Fetal Alcohol Spectrum Disorders; Gestational Age; Humans; Hydrops Fetalis; Hypoplastic Left Heart Syndrome; Infant, Newborn; Male; Oxazolidinones; Pregnancy; Pregnancy Complications; Pregnancy Outcome; Prenatal Care; Prognosis; Substance-Related Disorders; Tobacco Use; Ultrasonography, Prenatal | 2018 |
Drug dependence associated with triptans and ergot derivatives: a case/non-case study.
Topics: Claviceps; Dihydroergotamine; Ergotamine; Humans; Migraine Disorders; Oxazolidinones; Piperidines; Pyrrolidines; Risk; Substance-Related Disorders; Sumatriptan; Tryptamines | 2010 |
Ergot and triptan overuse in Austria--an evaluation of clinical data and cost.
Topics: Adult; Aged; Austria; Ergot Alkaloids; Female; Headache; Humans; Male; Middle Aged; Oxazolidinones; Retrospective Studies; Substance Withdrawal Syndrome; Substance-Related Disorders; Sumatriptan; Tryptamines | 2002 |